Resources and methods to rapidly evaluate the clinical utility of promising biomarker of risk and disease are critically needed. Preliminary assessment of promising serologic and genetic markers may be performed using available specimen banks. The proposed study will use an existing community-based cohort under follow-up for cancer outcomes. Participants donated blood specimens in 1974 (CLUE I) and 1989 (CLUE II). Serum/plasma, red blood cells and buffy coats have been stored at -70 degrees Centigrade 1989. As a member of the Early Detection Network we propose to set aside alliquots serum/plasma, red blood cells and DNA from existing cohort resources (over 58,000 specimens) as a network resource. We will expand the resource by collecting tissue specimens from Cohort participants who develop cancer. We propose to conduct another blood collection campaign in the year 2001. To obtain 40,000 blood specimens, encouraging previous CLUE participants to donate again. This will provide specimens on individuals from multiple time points and expand the cohort resources. To demonstrate the ability to rapidly and efficient evaluate multiple types of biomarkers for the early detection of cancer or markers of developing cancer we propose to study three promising biomarkers: Fatty acid synthase concentrations (FAS), a potent8ial marker for the early detection of aggressive forms of breast cancer; genetic polymorphisms in the XPD gene, a potential marker of susceptibility to the development of a second primary cancer among individuals with non-melanoma skin cancer; and tobacco-specific nitrosamine hemoglobin adducts (TSNA), a potential marker of risk for the development of lung cancer among smokers. The CLUE study cohorts will provide a mechanism to rapidly assess potential markers and aid in their transition from the laboratory to the clinical setting. The long-term characterization of the cohort and having multiple specimens are valuable for determining the validity (sensitivity and specificity) of biomarkers, changes in biomarkers over time, association with early vs late stages of carcinogenesis and assessing latency periods.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA086308-02
Application #
6362763
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (J1))
Project Start
2000-05-17
Project End
2005-02-28
Budget Start
2001-05-23
Budget End
2002-02-28
Support Year
2
Fiscal Year
2001
Total Cost
$865,161
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ose, Jennifer; Poole, Elizabeth M; Schock, Helena et al. (2017) Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium. Cancer Res 77:3951-3960
Ose, Jennifer; Schock, Helena; Poole, Elizabeth M et al. (2017) Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes Control 28:429-435
Waheed, Salman; Azad, Nilofer; Waheed, Sehrish et al. (2014) Racial disparities and colorectal cancer survival in older adults with and without diabetes mellitus. J Gastroenterol Hepatol 29:1963-8
Yeh, Hsin-Chieh; Platz, Elizabeth A; Wang, Nae-Yuh et al. (2012) A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 35:113-8
International Consortium for Blood Pressure Genome-Wide Association Studies (see original citation for additional authors) (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103-9
Lai, Gabriel Y; Helzlsouer, Kathy J; Clipp, Sandra L et al. (2010) Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study. Cancer Prev Res (Phila) 3:1334-41
Tsilidis, Konstantinos K; Brancati, Frederick L; Pollak, Michael N et al. (2010) Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 21:1-10
Mondul, Alison M; Clipp, Sandra L; Helzlsouer, Kathy J et al. (2010) Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control 21:61-8
Chen, Liwei; Gallicchio, Lisa; Boyd-Lindsley, Kristina et al. (2009) Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review. Nutr Cancer 61:1-15
Wang, Ming-Hsi; Helzlsouer, Kathy J; Smith, Michael W et al. (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 69:874-85

Showing the most recent 10 out of 35 publications